Guardant Health
GH
#1586
Rank
ยฃ9.83 B
Marketcap
ยฃ75.76
Share price
-1.21%
Change (1 day)
171.22%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -ยฃ2.45

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.40. In 2024 the company made an earnings per share (EPS) of -ยฃ2.66 an increase over its 2023 EPS that were of -ยฃ3.20.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.45-8.05%
2024-ยฃ2.66-16.82%
2023-ยฃ3.20-33.13%
2022-ยฃ4.7860%
2021-ยฃ2.9955.04%
2020-ยฃ1.93207.14%
2019-ยฃ0.63-19.81%
2018-ยฃ0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-ยฃ1.60-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-ยฃ3.59 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA